# pathway_0076

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MNPPPSLLDKAAIVTGGSRGIGAAIAIELARRGAHVLITYNTASHKAQLVAEEIQKLGRKATVVQASSTDREGPNRIVQAAVSQYGRIDIIVNNAGMADDCLLQDLTHEFWDRIMDVNLRLPAFLVQAALQHLGPAPRIVNISSLAARAGYNATSVYAASKAALEGMTRAWATELGHRYNVTVNCVNPGPVDTDIMAVDENTDAEVVAYWNAKVKETPAAPRVGTPGDIAQIVAFLCEEGSRWCTGSVVNANGGLVTV

[Multiple Choices]
A. molybdopterin biosynthesis. .
B. L-methionine biosynthesis via de novo pathway. .
C. chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step 7/7. .
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The matched UniProt record annotates this sequence's pathway as secondary metabolite biosynthesis, and the historical record available by the stated cutoff carries the same annotation. The annotation cites a paper on FR901483 biosynthesis, though the supplied excerpts do not independently establish the paper's experimental findings.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has features consistent with an enzyme, but those features do not identify its pathway or distinguish secondary-metabolite biosynthesis from the other listed pathways.


**Missing item-specific fact**

> The protein's specific role in the FR901483 biosynthetic cluster, or an equivalent pathway annotation, is absent from the input.


**Reason**

> Selecting D depends on protein-specific functional knowledge not inferable from the sequence and choices alone; recognizing the sequence or recalling its annotation would be lookup or memorization, not supplied-input reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The source annotation directly matches choice D; the sequence alone does not provide a basis for choosing a competing option.


### Important caveats

- The source annotation is linked to a cited publication and marked with experimental evidence, but the excerpts do not include the underlying experimental results.
- Reviewer-only accession and annotation information was not supplied to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has features consistent with an enzyme, but those features do not identify its pathway or distinguish secondary-metabolite biosynthesis from the other listed pathways.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific role in the FR901483 biosynthetic cluster, or an equivalent pathway annotation, is absent from the input.",
    "reason": "Selecting D depends on protein-specific functional knowledge not inferable from the sequence and choices alone; recognizing the sequence or recalling its annotation would be lookup or memorization, not supplied-input reasoning."
  },
  "case_id": "pathway_0076",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The matched UniProt record annotates this sequence's pathway as secondary metabolite biosynthesis, and the historical record available by the stated cutoff carries the same annotation. The annotation cites a paper on FR901483 biosynthesis, though the supplied excerpts do not independently establish the paper's experimental findings."
  },
  "important_caveats": [
    "The source annotation is linked to a cited publication and marked with experimental evidence, but the excerpts do not include the underlying experimental results.",
    "Reviewer-only accession and annotation information was not supplied to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The source annotation directly matches choice D; the sequence alone does not provide a basis for choosing a competing option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0076",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched UniProt record annotates this sequence's pathway as secondary metabolite biosynthesis, and the historical record available by the stated cutoff carries the same annotation. The annotation cites a paper on FR901483 biosynthesis, though the supplied excerpts do not independently establish the paper's experimental findings.",
    "evidence_ids": ["C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has features consistent with an enzyme, but those features do not identify its pathway or distinguish secondary-metabolite biosynthesis from the other listed pathways.",
    "missing_item_specific_fact": "The protein's specific role in the FR901483 biosynthetic cluster, or an equivalent pathway annotation, is absent from the input.",
    "reason": "Selecting D depends on protein-specific functional knowledge not inferable from the sequence and choices alone; recognizing the sequence or recalling its annotation would be lookup or memorization, not supplied-input reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The source annotation directly matches choice D; the sequence alone does not provide a basis for choosing a competing option."
  },
  "important_caveats": [
    "The source annotation is linked to a cited publication and marked with experimental evidence, but the excerpts do not include the underlying experimental results.",
    "Reviewer-only accession and annotation information was not supplied to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A7T8F1N2 (FRZI_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:33372776 (Zhang et al., JACS 2021, 'Biosynthesis of the Immunosuppressant (-)-FR901483'). The protein is FrzI, a short-chain dehydrogenase/reductase in the FR901483 biosynthetic gene cluster of Cladobotryum sp. The sequence matches exactly (SHA256 confirmed). The annotation is experimentally derived, not merely computational.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains canonical SDR (short-chain dehydrogenase/reductase) motifs (GGSRGIGAAIA Rossmann fold NAD-binding motif, NAGMADDCLLQ region), confirming it is an SDR. However, SDRs are among the most ubiquitous enzyme families and participate in all four listed pathways: molybdopterin biosynthesis contains reductase steps, methionine biosynthesis includes SDR-type enzymes, chorismate biosynthesis involves various oxidoreductases, and secondary metabolite biosynthesis is replete with SDRs. The sequence alone provides no substrate-specific or pathway-specific motif that would exclude options A, B, or C in favor of D.


**Missing item-specific fact**

> The experimental characterization from PubMed:33372776 demonstrating that this specific SDR (FrzI) catalyzes a step in the FR901483 immunosuppressant biosynthetic cluster is required. Without knowing the protein's identity and its gene-cluster context, no sequence-based argument distinguishes this SDR as functioning in secondary metabolite biosynthesis rather than in one of the other listed primary metabolic pathways.


**Reason**

> Identifying the protein as an SDR from the Rossmann fold motif is possible from the sequence, but SDRs are found in every listed pathway. The assignment to 'Secondary metabolite biosynthesis' specifically requires knowledge of this protein's experimental characterization as FrzI in the FR901483 cluster. This is a protein-specific experimental fact absent from the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While option D is extremely broad (encompassing thousands of pathways) compared to the very specific options A-C, the other three options name specific well-characterized pathway steps (molybdopterin biosynthesis, de novo methionine biosynthesis, chorismate synthase step 7/7) whose enzyme families and sequence signatures are distinct from this particular SDR. No alternative option is genuinely defensible for this sequence, but the reasoning to exclude them still requires protein-specific knowledge rather than general sequence analysis.


### Important caveats

- The pathway annotation 'Secondary metabolite biosynthesis' is a very broad UniProt category; the actual specific pathway is FR901483 (an immunosuppressant) biosynthesis, which falls under this umbrella.
- The sequence provides no organism information, which would be needed even for broad taxonomic reasoning (e.g., fungal secondary metabolism).
- The SDR fold is shared across primary and secondary metabolism; recognizing the fold does not determine the pathway.
- The entry was first public in June 2025; depending on the author's data-construction date, this annotation may or may not have been available in the source snapshot.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains canonical SDR (short-chain dehydrogenase/reductase) motifs (GGSRGIGAAIA Rossmann fold NAD-binding motif, NAGMADDCLLQ region), confirming it is an SDR. However, SDRs are among the most ubiquitous enzyme families and participate in all four listed pathways: molybdopterin biosynthesis contains reductase steps, methionine biosynthesis includes SDR-type enzymes, chorismate biosynthesis involves various oxidoreductases, and secondary metabolite biosynthesis is replete with SDRs. The sequence alone provides no substrate-specific or pathway-specific motif that would exclude options A, B, or C in favor of D.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The experimental characterization from PubMed:33372776 demonstrating that this specific SDR (FrzI) catalyzes a step in the FR901483 immunosuppressant biosynthetic cluster is required. Without knowing the protein's identity and its gene-cluster context, no sequence-based argument distinguishes this SDR as functioning in secondary metabolite biosynthesis rather than in one of the other listed primary metabolic pathways.",
    "reason": "Identifying the protein as an SDR from the Rossmann fold motif is possible from the sequence, but SDRs are found in every listed pathway. The assignment to 'Secondary metabolite biosynthesis' specifically requires knowledge of this protein's experimental characterization as FrzI in the FR901483 cluster. This is a protein-specific experimental fact absent from the input."
  },
  "case_id": "pathway_0076",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8F1N2 (FRZI_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:33372776 (Zhang et al., JACS 2021, 'Biosynthesis of the Immunosuppressant (-)-FR901483'). The protein is FrzI, a short-chain dehydrogenase/reductase in the FR901483 biosynthetic gene cluster of Cladobotryum sp. The sequence matches exactly (SHA256 confirmed). The annotation is experimentally derived, not merely computational."
  },
  "important_caveats": [
    "The pathway annotation 'Secondary metabolite biosynthesis' is a very broad UniProt category; the actual specific pathway is FR901483 (an immunosuppressant) biosynthesis, which falls under this umbrella.",
    "The sequence provides no organism information, which would be needed even for broad taxonomic reasoning (e.g., fungal secondary metabolism).",
    "The SDR fold is shared across primary and secondary metabolism; recognizing the fold does not determine the pathway.",
    "The entry was first public in June 2025; depending on the author's data-construction date, this annotation may or may not have been available in the source snapshot."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While option D is extremely broad (encompassing thousands of pathways) compared to the very specific options A-C, the other three options name specific well-characterized pathway steps (molybdopterin biosynthesis, de novo methionine biosynthesis, chorismate synthase step 7/7) whose enzyme families and sequence signatures are distinct from this particular SDR. No alternative option is genuinely defensible for this sequence, but the reasoning to exclude them still requires protein-specific knowledge rather than general sequence analysis."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0076",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A7T8F1N2 (FRZI_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:33372776 (Zhang et al., JACS 2021, 'Biosynthesis of the Immunosuppressant (-)-FR901483'). The protein is FrzI, a short-chain dehydrogenase/reductase in the FR901483 biosynthetic gene cluster of Cladobotryum sp. The sequence matches exactly (SHA256 confirmed). The annotation is experimentally derived, not merely computational.",
    "evidence_ids": ["C5", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains canonical SDR (short-chain dehydrogenase/reductase) motifs (GGSRGIGAAIA Rossmann fold NAD-binding motif, NAGMADDCLLQ region), confirming it is an SDR. However, SDRs are among the most ubiquitous enzyme families and participate in all four listed pathways: molybdopterin biosynthesis contains reductase steps, methionine biosynthesis includes SDR-type enzymes, chorismate biosynthesis involves various oxidoreductases, and secondary metabolite biosynthesis is replete with SDRs. The sequence alone provides no substrate-specific or pathway-specific motif that would exclude options A, B, or C in favor of D.",
    "missing_item_specific_fact": "The experimental characterization from PubMed:33372776 demonstrating that this specific SDR (FrzI) catalyzes a step in the FR901483 immunosuppressant biosynthetic cluster is required. Without knowing the protein's identity and its gene-cluster context, no sequence-based argument distinguishes this SDR as functioning in secondary metabolite biosynthesis rather than in one of the other listed primary metabolic pathways.",
    "reason": "Identifying the protein as an SDR from the Rossmann fold motif is possible from the sequence, but SDRs are found in every listed pathway. The assignment to 'Secondary metabolite biosynthesis' specifically requires knowledge of this protein's experimental characterization as FrzI in the FR901483 cluster. This is a protein-specific experimental fact absent from the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While option D is extremely broad (encompassing thousands of pathways) compared to the very specific options A-C, the other three options name specific well-characterized pathway steps (molybdopterin biosynthesis, de novo methionine biosynthesis, chorismate synthase step 7/7) whose enzyme families and sequence signatures are distinct from this particular SDR. No alternative option is genuinely defensible for this sequence, but the reasoning to exclude them still requires protein-specific knowledge rather than general sequence analysis."
  },
  "important_caveats": [
    "The pathway annotation 'Secondary metabolite biosynthesis' is a very broad UniProt category; the actual specific pathway is FR901483 (an immunosuppressant) biosynthesis, which falls under this umbrella.",
    "The sequence provides no organism information, which would be needed even for broad taxonomic reasoning (e.g., fungal secondary metabolism).",
    "The SDR fold is shared across primary and secondary metabolism; recognizing the fold does not determine the pathway.",
    "The entry was first public in June 2025; depending on the author's data-construction date, this annotation may or may not have been available in the source snapshot."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8F1N2` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 16. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1N2.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:50.517832+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"Secondary metabolite biosynthesis"}]}
```

Source SHA-256: `a48d33ae046ca7d2880e19af31acc95da30a7d81466d9e58266bba934f1fdd76`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1N2.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:50.517832+00:00.  

```json
{"citation":{"authors":["Zhang Z.","Tamura Y.","Tang M.","Qiao T.","Sato M.","Otsu Y.","Sasamura S.","Taniguchi M.","Watanabe K.","Tang Y."],"citationCrossReferences":[{"database":"PubMed","id":"33372776"},{"database":"DOI","id":"10.1021/jacs.0c12352"}],"citationType":"journal article","firstPage":"132","id":"33372776","journal":"J. Am. Chem. Soc.","lastPage":"136","publicationDate":"2021","title":"Biosynthesis of the Immunosuppressant (-)-FR901483.","volume":"143"},"referenceComments":[{"type":"STRAIN","value":"11231"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `a48d33ae046ca7d2880e19af31acc95da30a7d81466d9e58266bba934f1fdd76`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1N2?format=txt&versions=16)  
**Locator:** `lines 14-22`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 16 / 1.  
**Retrieved:** 2026-11-02T04:25:54.316010+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=11231;
RX   PubMed=33372776; DOI=10.1021/jacs.0c12352;
RA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,
RA   Taniguchi M., Watanabe K., Tang Y.;
RT   "Biosynthesis of the Immunosuppressant (-)-FR901483.";
RL   J. Am. Chem. Soc. 143:132-136(2021).
```

Source SHA-256: `ea33ab978987653ceb1106c71afcee5b805fc9a5d38cccf91ee029364fdb1198`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1N2?format=txt&versions=16)  
**Locator:** `lines 63-64`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 16 / 1.  
**Retrieved:** 2026-11-02T04:25:54.316010+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `ea33ab978987653ceb1106c71afcee5b805fc9a5d38cccf91ee029364fdb1198`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 76. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
